PE20070416A1 - Compuestos peptidicos como agonistas del receptor de trombopoyetina - Google Patents
Compuestos peptidicos como agonistas del receptor de trombopoyetinaInfo
- Publication number
- PE20070416A1 PE20070416A1 PE2006000953A PE2006000953A PE20070416A1 PE 20070416 A1 PE20070416 A1 PE 20070416A1 PE 2006000953 A PE2006000953 A PE 2006000953A PE 2006000953 A PE2006000953 A PE 2006000953A PE 20070416 A1 PE20070416 A1 PE 20070416A1
- Authority
- PE
- Peru
- Prior art keywords
- receptor
- trombopoyetin
- agonists
- succinate
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 abstract 2
- 102100037644 Kelch-like protein 41 Human genes 0.000 abstract 1
- 108050003242 Kelch-like protein 41 Proteins 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- NPKKRSHVJIQBKU-UHFFFAOYSA-N ornogenin Natural products CC(OC(=O)C=Cc1ccccc1)C2(O)CCC3(O)C4(O)CC=C5CC(O)CCC5(C)C4CC(OC(=O)C=Cc6ccccc6)C23C NPKKRSHVJIQBKU-UHFFFAOYSA-N 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 206010043554 thrombocytopenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/200,416 US7723295B2 (en) | 2003-08-28 | 2005-08-09 | Peptides and compounds that bind to a receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070416A1 true PE20070416A1 (es) | 2007-06-13 |
Family
ID=37734435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000953A PE20070416A1 (es) | 2005-08-09 | 2006-08-07 | Compuestos peptidicos como agonistas del receptor de trombopoyetina |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US7723295B2 (https=) |
| EP (1) | EP1957517B1 (https=) |
| JP (1) | JP2009504650A (https=) |
| KR (1) | KR20080048026A (https=) |
| CN (1) | CN101287749A (https=) |
| AR (1) | AR055114A1 (https=) |
| AU (1) | AU2006280230B2 (https=) |
| BR (1) | BRPI0614647A2 (https=) |
| CA (1) | CA2618958A1 (https=) |
| CR (1) | CR9798A (https=) |
| CY (1) | CY1114032T1 (https=) |
| DK (1) | DK1957517T3 (https=) |
| EA (1) | EA200800535A1 (https=) |
| EC (1) | ECSP088169A (https=) |
| ES (1) | ES2419005T3 (https=) |
| GT (1) | GT200600361A (https=) |
| HR (1) | HRP20130518T1 (https=) |
| IL (1) | IL189361A (https=) |
| JO (1) | JO2859B1 (https=) |
| MY (1) | MY152177A (https=) |
| NI (1) | NI200800040A (https=) |
| NO (1) | NO344405B1 (https=) |
| NZ (1) | NZ565497A (https=) |
| PE (1) | PE20070416A1 (https=) |
| PL (1) | PL1957517T3 (https=) |
| PT (1) | PT1957517E (https=) |
| RS (1) | RS52802B (https=) |
| SI (1) | SI1957517T1 (https=) |
| SV (1) | SV2008002648A (https=) |
| TW (1) | TWI400081B (https=) |
| UA (1) | UA96418C2 (https=) |
| UY (1) | UY29736A1 (https=) |
| WO (1) | WO2007021572A2 (https=) |
| ZA (1) | ZA200802184B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091311B2 (en) * | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
| KR20050093759A (ko) | 2002-09-18 | 2005-09-23 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법 |
| US20040149235A1 (en) * | 2002-10-04 | 2004-08-05 | Pogue Albert S. | Apparatus and method for removal of waste from animal production facilities |
| US7615533B2 (en) * | 2004-08-16 | 2009-11-10 | Janssen Pharmaceutica N.V. | TPO peptide compounds for treatment of anemia |
| US20090053242A1 (en) * | 2006-01-25 | 2009-02-26 | Amgen Inc. | Thrombopoietic compounds |
| KR20110015448A (ko) * | 2008-06-03 | 2011-02-15 | 얀센 파마슈티카 엔.브이. | 암 치료와 관련된 혈액 질환을 예방하기 위한 ｔｐｏ 모방 펩티드 |
| EP2725053B1 (en) | 2011-06-23 | 2016-02-10 | Shimadzu Corporation | Branched amphipathic block polymer and molecular aggregate and drug delivery system using same |
| CA3070442A1 (en) | 2017-07-26 | 2019-01-31 | Janssen Pharmaceutica Nv | Methods of protecting vascular integrity induced by targeted radiation therapy |
| MX2021008928A (es) | 2019-01-25 | 2021-11-04 | Janssen Pharmaceutica Nv | Métodos para mejorar la protección contra lesiones vasculares y de organos, la recuperación hematopoyética y la supervivencia en respuesta a la radiacion corporal total/exposicion química. |
| CN113905754B (zh) | 2019-01-25 | 2025-03-11 | 詹森药业有限公司 | 减轻起疱剂和腐蚀性气体毒性作用的方法 |
| CN113766926A (zh) | 2019-01-25 | 2021-12-07 | 詹森药业有限公司 | 与放射和/或放射模拟物治疗结合的减轻肝损伤和促进肝肥大、再生和细胞植入的方法 |
| US20240156973A1 (en) * | 2021-02-24 | 2024-05-16 | Purdue Research Foundation | Osteotropic compositions and uses thereof |
| WO2023056444A1 (en) | 2021-10-01 | 2023-04-06 | Janssen Pharmaceutica N.V. | Methods of increasing progenitor cell production |
| WO2024095178A1 (en) | 2022-11-01 | 2024-05-10 | Janssen Pharmaceutica Nv | Thrombopoietin mimetic for use in the treatment of acute liver failure |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5326558A (en) * | 1989-08-08 | 1994-07-05 | Genetics Institute, Inc. | Megakaryocytopoietic factor |
| IL96477A0 (en) | 1989-12-01 | 1991-08-16 | Amgen Inc | Megakaryocyte production |
| DK167813B1 (da) * | 1989-12-07 | 1993-12-20 | Carlbiotech Ltd As | Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat |
| US5571508A (en) | 1989-12-18 | 1996-11-05 | Amrad Corporation Limited | Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor |
| IT1241395B (it) | 1990-04-02 | 1994-01-10 | Eniricerche Spa | Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria |
| US5141851A (en) * | 1990-04-18 | 1992-08-25 | Board Of Regents, The University Of Texas System | Isolated farnesyl protein transferase enzyme |
| US5250732A (en) * | 1991-07-18 | 1993-10-05 | Genentech, Inc. | Ketamine analogues for treatment of thrombocytopenia |
| US5270170A (en) * | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
| ES2181691T5 (es) | 1992-06-11 | 2007-10-01 | Alkermes Controlled Therapeutics, Inc. | Sistema de distribucion de proteina eritropoyetina. |
| JP3401005B2 (ja) * | 1992-12-11 | 2003-04-28 | ユニバーシティ オブ フロリダ | 有害生物の防除のための材料および方法 |
| AU8124694A (en) | 1993-10-29 | 1995-05-22 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| SG47030A1 (en) | 1994-01-03 | 1998-03-20 | Genentech Inc | Thrombopoietin |
| SK100896A3 (en) | 1994-02-14 | 1997-10-08 | Zymogenetics Inc | Hematopoietic protein and materials and methods for making it |
| EP0668352A1 (en) | 1994-02-14 | 1995-08-23 | Kirin Brewery Company, Ltd. | Protein having TPO activity |
| WO1995021626A1 (en) | 1994-02-14 | 1995-08-17 | University Of Washington | Methods for stimulating erythropoiesis using thrombopoietin |
| WO1995021919A2 (en) | 1994-02-14 | 1995-08-17 | Kirin Brewery Company, Limited | Protein having tpo activity |
| CN1229385C (zh) | 1994-03-31 | 2005-11-30 | 安姆根有限公司 | 刺激巨核细胞生长和分化的组合物及方法 |
| US5571686A (en) | 1994-04-14 | 1996-11-05 | Massachusetts Institute Of Technology | Method of using megapoietin for prolonging the survival & viability of platlets |
| AU4163196A (en) | 1994-11-30 | 1996-06-19 | Zymogenetics Inc. | Low molecular weight thrombopoietin |
| AU705064B2 (en) | 1995-04-26 | 1999-05-13 | Kyowa Hakko Kogyo Co. Ltd. | Novel polypeptides |
| TR199701526T1 (xx) * | 1995-06-07 | 1998-03-21 | Glaxo Group Limited | Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler. |
| US5869451A (en) | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US6251864B1 (en) * | 1995-06-07 | 2001-06-26 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
| US6060052A (en) * | 1995-10-30 | 2000-05-09 | Systemix, Inc. | Methods for use of Mpl ligands with primitive human hematopoietic stem cells |
| US5932546A (en) * | 1996-10-04 | 1999-08-03 | Glaxo Wellcome Inc. | Peptides and compounds that bind to the thrombopoietin receptor |
| ATE350044T1 (de) | 1999-09-24 | 2007-01-15 | Smithkline Beecham Corp | Thrombopoietinmimetika |
| AU2002307062A1 (en) | 2001-04-02 | 2002-10-15 | Purdue Pharma L.P. | Thrombopoietin (tpo) synthebody for stimulation of platelet production |
| KR20050093759A (ko) | 2002-09-18 | 2005-09-23 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법 |
| US7576056B2 (en) | 2003-08-28 | 2009-08-18 | Ortho-Mcneil Pharmaceutical, Inc. | Peptides and compounds that bind to a receptor |
-
2005
- 2005-08-09 US US11/200,416 patent/US7723295B2/en active Active
-
2006
- 2006-08-03 ES ES06789357T patent/ES2419005T3/es active Active
- 2006-08-03 SI SI200631599T patent/SI1957517T1/sl unknown
- 2006-08-03 UA UAA200801217A patent/UA96418C2/ru unknown
- 2006-08-03 PL PL06789357T patent/PL1957517T3/pl unknown
- 2006-08-03 NZ NZ565497A patent/NZ565497A/en not_active IP Right Cessation
- 2006-08-03 JP JP2008526082A patent/JP2009504650A/ja active Pending
- 2006-08-03 WO PCT/US2006/030359 patent/WO2007021572A2/en not_active Ceased
- 2006-08-03 BR BRPI0614647-3A patent/BRPI0614647A2/pt not_active Application Discontinuation
- 2006-08-03 CN CNA2006800376102A patent/CN101287749A/zh active Pending
- 2006-08-03 EA EA200800535A patent/EA200800535A1/ru unknown
- 2006-08-03 EP EP06789357A patent/EP1957517B1/en active Active
- 2006-08-03 AU AU2006280230A patent/AU2006280230B2/en not_active Ceased
- 2006-08-03 DK DK06789357.8T patent/DK1957517T3/da active
- 2006-08-03 PT PT67893578T patent/PT1957517E/pt unknown
- 2006-08-03 HR HRP20130518TT patent/HRP20130518T1/hr unknown
- 2006-08-03 RS RS20130193A patent/RS52802B/sr unknown
- 2006-08-03 CA CA002618958A patent/CA2618958A1/en active Pending
- 2006-08-03 KR KR1020087005576A patent/KR20080048026A/ko not_active Ceased
- 2006-08-07 PE PE2006000953A patent/PE20070416A1/es not_active Application Discontinuation
- 2006-08-07 GT GT200600361A patent/GT200600361A/es unknown
- 2006-08-07 MY MYPI20063814 patent/MY152177A/en unknown
- 2006-08-08 TW TW095128950A patent/TWI400081B/zh not_active IP Right Cessation
- 2006-08-08 JO JO2006266A patent/JO2859B1/en active
- 2006-08-08 AR ARP060103451A patent/AR055114A1/es unknown
- 2006-08-09 UY UY29736A patent/UY29736A1/es not_active Application Discontinuation
- 2006-08-09 SV SV2006002648A patent/SV2008002648A/es not_active Application Discontinuation
-
2008
- 2008-02-07 IL IL189361A patent/IL189361A/en active IP Right Grant
- 2008-02-07 NI NI200800040A patent/NI200800040A/es unknown
- 2008-02-08 EC EC2008008169A patent/ECSP088169A/es unknown
- 2008-03-06 CR CR9798A patent/CR9798A/es not_active Application Discontinuation
- 2008-03-07 ZA ZA200802184A patent/ZA200802184B/xx unknown
- 2008-03-10 NO NO20081298A patent/NO344405B1/no unknown
-
2013
- 2013-06-06 CY CY20131100452T patent/CY1114032T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20070416A1 (es) | Compuestos peptidicos como agonistas del receptor de trombopoyetina | |
| DE602007011901D1 (de) | Ptiden und zellpenetrierenden peptiden gekoppelt a | |
| Massaguer et al. | Integrin-targeted delivery into cancer cells of a Pt (IV) pro-drug through conjugation to RGD-containing peptides | |
| EP1948241B1 (en) | Multi-drug ligand conjugates | |
| CN102711789B (zh) | 用于降低甲状旁腺激素水平的治疗剂 | |
| US12296018B2 (en) | Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same | |
| PH12014501642B1 (en) | Peptide vaccines for cancers expressing tumor-associated antigens | |
| US12115224B2 (en) | Polypeptide conjugates for intracellular delivery of stapled peptides | |
| US20180185498A1 (en) | Prodrugs activated by caspase | |
| AR045530A1 (es) | Peptidos y compuestos que se unen al receptor de trombopoyetina | |
| EP2496245A4 (en) | ANALOG OF PITUTIC ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND METHOD OF USE THEREOF | |
| RU2010153217A (ru) | Пептидные аналоги альфа-меланоцитстимулирующего гормона | |
| BRPI0511966A (pt) | composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons | |
| Bodero et al. | Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting | |
| EA026870B1 (ru) | Комбинация и фармацевтическая композиция для лечения опухолей | |
| TW202227139A (zh) | Fap活化之血清延長半衰期治療結合物 | |
| JP2018521977A5 (https=) | ||
| TR201807811T4 (tr) | Bileşikler. | |
| Tripodi et al. | Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property | |
| MX2022011287A (es) | Peptidos ciclicos y sus conjugados para el direccionamiento de la integrina alfa-v-beta-6 in vivo. | |
| PE20010587A1 (es) | Composicion que comprende conjugados de polimeros funcionales como inhibidores de enzimas proteoliticas | |
| KR20140035456A (ko) | 혈청 인을 조절하는 치료제 | |
| US11208443B2 (en) | NAF-1 derived peptides and uses thereof | |
| Prasad et al. | Substance P analogs containing α, α‐dialkylated amino acids with potent anticancer activity | |
| Wenk et al. | Integrin and matrix metalloprotease dual-targeting with an MMP substrate–RGD conjugate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal | ||
| AE | Restoration of lapsed or forfeited application | ||
| FC | Refusal |